Singapore markets closed

TLRY Jan 2025 0.500 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.03000.0000 (0.00%)
As of 10:37AM EDT. Market open.
Full screen
Previous close0.0300
Open0.0300
Bid0.0000
Ask0.0000
Strike0.50
Expiry date2025-01-17
Day's range0.0300 - 0.0300
Contract rangeN/A
Volume88
Open interest481
  • GlobeNewswire

    Tilray Medical Granted Approval to Introduce Third Medical Cannabis Product in Portugal

    Tilray's Solução Oral THC10:CBD10 Medical Cannabis Extract is Now Approved for Medical Use in PortugalCANTANHEDE, Portugal, July 24, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced another milestone achievement in medical cannabis in Europe. Following the successful approval of Tilray Medical whole flower THC 18, and approval for the first cannabis extract in Portug

  • Zacks

    Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights

    Tilray Brands, Inc. (TLRY) closed at $1.89 in the latest trading session, marking a -1.56% move from the prior day.

  • GlobeNewswire

    Tilray Receives First New Cannabis Cultivation License in Germany Under New Regulations

    Tilray's Aphria RX Facility in Germany Granted New Cannabis Cultivation License, Allowing for ~5x Production Increase and New Strains to Enhance Patient Access Across the Country Aphria RX Designed with Guidance from Renowned Cannabis Grower of Broken Coast Cannabis NEUMÜNSTER, Germany, July 22, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global leader in cannabis research, cultivation, production, and distribution, today announced that its Germany cannab